These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15545787

  • 1. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.
    van Rooij IA, Tonkelaar Id, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER.
    Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M, Skull JD, Ledger WL.
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.
    Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J.
    Hum Reprod; 2003 Feb; 18(2):323-7. PubMed ID: 12571168
    [Abstract] [Full Text] [Related]

  • 9. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system.
    Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3060-7. PubMed ID: 17550960
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P.
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status.
    Shin SY, Lee JR, Noh GW, Kim HJ, Kang WJ, Kim SH, Chung JK.
    J Korean Med Sci; 2008 Feb; 23(1):104-10. PubMed ID: 18303208
    [Abstract] [Full Text] [Related]

  • 15. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.
    Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I.
    J Assist Reprod Genet; 2011 Dec; 28(12):1197-203. PubMed ID: 21882017
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.